The quick increase of morbidity, caused by the endometrial carcinoma in our country during recent 15 years from 5,2 to 16,5 per 100,000 raises acutely the question about effective primary and secondary prophylaxis. Having in mind the role of hyperestrogenemia in the etiology of endometrial carcinoma and the fact that the results from its treatment are determined basically by the degree of distribution of the tumor, the authors think that it is necessary fight for rational feeding, timely treatment of the disease with hyperestrogenemia and prophylactic therapy with gestagens. Cytologic examination of aspirate, obtained from the uterine cavity, is proposed as screening method for women of the risk groups. A scheme of management of women with pathological R3-5 group is proposed.